Trial Profile
A Phase IV Study of Teneligliptin (MP-513) in Combination With Insulin in Japanese Patients With Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Apr 2023
Price :
$35
*
At a glance
- Drugs Teneligliptin (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 08 May 2016 Status changed from active, no longer recruiting to completed.
- 23 Jul 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
- 14 Mar 2014 New trial record